References
- Akkiz H, Bayram S, Bekar A, Akgollu E, Ulger, Y (2011a). A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat, 18, 399-407. https://doi.org/10.1111/j.1365-2893.2010.01414.x
- Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O (2011b). Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev, 12, 3107-12.
- Bae JS, Kim JH, Pasaje CF, et al (2012). Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases. Dig Liver Dis, 44, 849-54. https://doi.org/10.1016/j.dld.2012.04.021
- Bhattacharya A, Cui Y (2015). miR2GO: comparative functional analysis for microRNAs. Bioinformatics, 31, 2403-5. https://doi.org/10.1093/bioinformatics/btv140
- Cairns P (2010). Renal cell carcinoma. Cancer Biomark, 9, 461-73.
- Chen C, Yang S, Chaugai S, Wang Y, Wan DW (2014). Metaanalysis of Hsa-mir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies. BMC Med Genet, 15, 126.
- Chow WH, Dong LM, Devesa SS (2010). Epidemiology and risk factors for kidney cancer. Nat Rev Urol, 7, 245-57. https://doi.org/10.1038/nrurol.2010.46
- De la Chapelle A, Jazdzewski K (2011). MicroRNAs in thyroid cancer. J Clin Endocrinol Metab, 96, 3326-36. https://doi.org/10.1210/jc.2011-1004
- Du M, Lu D, Wang Q, et al (2014). Genetic variations in microRNAs and the risk and survival of renal cell cancer. Carcinogenesis, 35, 1629-35. https://doi.org/10.1093/carcin/bgu082
- Geeleher P, Huang SR, Gamazon ER, Golden A, Seoighe C (2012). The regulatory effect of miRNAs is a heritable genetic trait in humans. BMC Genomics, 3, 383.
- Guo J, Jin M, Zhang M, Chen K (2012). A genetic variant in miR-196a2 increased digestive system cancer risks: a metaanalysis of 15 case-control studies. PLoS ONE, 7, 30585. https://doi.org/10.1371/journal.pone.0030585
- He B, Pan Y, Cho WC, et al (2012). The Association between Four Genetic Variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS ONE, 7, 49032. https://doi.org/10.1371/journal.pone.0049032
- Hoffman AE, Zheng T, Yi C, et al (2009). microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res, 69, 5970-7. https://doi.org/10.1158/0008-5472.CAN-09-0236
- Hornstein E, Mansfield JH, Yekta S, et al (2005). The microRNA miR-196 acts upstream of Hoxb8 sand Shh in limb development. Nature, 438, 671-4. https://doi.org/10.1038/nature04138
- Hou W, Tian Q, Zheng J, Bonkovsky HL (2010). MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatol, 51, 1494-504. https://doi.org/10.1002/hep.23401
- Hu Z, Liang J, Wang Z, et al (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat, 30, 79-84. https://doi.org/10.1002/humu.20837
- Hu Z, Chen J, Tian T, et al (2008). Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest, 118, 2600-8.
- Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004). The KEGG resource for deciphering the genome. Nucleic Acids Res, 32, 277-80. https://doi.org/10.1093/nar/gkh063
- Kar P (2014). Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol, 4, S34-S42.
- Kim WH, Min KT, Jeon YJ, et al (2012). Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene, 504, 92-7. https://doi.org/10.1016/j.gene.2012.05.014
- Kwak MS, Lee DH, Cho Y, et al (2012). Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. PLoS ONE, 27, 41983.
- Li XD, Li ZG, Song XX, Liu CF (2010). A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathol, 42, 669-73. https://doi.org/10.3109/00313025.2010.522175
- Liu Y, Zhang Y, Wen J, et al (2012). A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS ONE, 7, 32230. https://doi.org/10.1371/journal.pone.0032230
- Min KT, Kim JW, Jeon YJ, et al (2012). Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog, 51, 65-73. https://doi.org/10.1002/mc.21849
- Moradpour D, Blum HE (2005). Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 17, 477-83. https://doi.org/10.1097/00042737-200505000-00002
- Morishita A, Masaki T (2015). miRNA in hepatocellular carcinoma. Hepatol Res, 45, 128-41. https://doi.org/10.1111/hepr.12386
- Muglia VF, Prando A (2015). Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras, 48, 166-74. https://doi.org/10.1590/0100-3984.2013.1927
- Popat K, McQueen K, Feeley TW (2013). The global burden of cancer. Best Pract Res Clin Anaesthesiol, 27, 399-408. https://doi.org/10.1016/j.bpa.2013.10.010
- Qi P, Dou TH, Geng L, et al (2010). Association of a variant in miR-196a2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol, 71, 1-626. https://doi.org/10.1016/j.humimm.2009.08.011
- Qin YR, Tang H, Xie F, et al (2011). Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res, 17, 46-55. https://doi.org/10.1158/1078-0432.CCR-10-1155
- Ryan BM, Robles AI, Harris CC (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer, 10, 389-402. https://doi.org/10.1038/nrc2867
- Tano K, Mizuno R, Okada T, et al (2010). MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett, 584, 4575-80. https://doi.org/10.1016/j.febslet.2010.10.008
- Visone R, Croce CM (2009). MiRNAs and cancer. Am J Pathol, 174, 1131-8. https://doi.org/10.2353/ajpath.2009.080794
- Vlachos IS, Kostoulas N, Vergoulis T et al (2012). DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res, 40, 498-504. https://doi.org/10.1093/nar/gks494
- Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M (2014). Mechanisms of mirna-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics, 2014, 970607.
- Xiang Y, Fan S, Cao J, Huang S, Zhang LP (2012). Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep, 39, 7019-23. https://doi.org/10.1007/s11033-012-1532-0
- Xu W, Xu J, Liu S (2011). Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146aon cancer susceptibility: a meta-analysis. PLoS ONE, 6, 20471. https://doi.org/10.1371/journal.pone.0020471
- Xu Y, Liu L, Liu J, et al (2011). A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular, carcinoma. Int J Cancer, 128, 412-7. https://doi.org/10.1002/ijc.25342
- Ye Y, Wang KK, Gu J, et al (2008). Genetic variations in microrna-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res, 1, 460-9. https://doi.org/10.1158/1940-6207.CAPR-08-0135